# Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial

> **NCT03075072** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 196 (estimated)

## Conditions studied

- Brain Metastases

## Interventions

- **RADIATION:** Whole brain radiation
- **RADIATION:** Stereotactic radiation (SRS)

## Key facts

- **NCT ID:** NCT03075072
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-04-10
- **Primary completion:** 2024-11-07
- **Final completion:** 2025-09-30
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2024-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03075072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03075072, "Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03075072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*